Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment for liver cancer: From sorafenib to natural products
Shuli Man, Chen Luo, Mengyao Yan, et al.
European Journal of Medicinal Chemistry (2021) Vol. 224, pp. 113690-113690
Closed Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Targeting the PDGF/PDGFR signaling pathway for cancer therapy: A review
Zou Xiang, Xi-Yu Tang, Zhongyuan Qu, et al.
International Journal of Biological Macromolecules (2022) Vol. 202, pp. 539-557
Closed Access | Times Cited: 117
Targeted therapy for osteosarcoma: a review
Shizhe Li, He Zhang, Jinxin Liu, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 9, pp. 6785-6797
Closed Access | Times Cited: 38
Inhibition of inflammation by berberine: Molecular mechanism and network pharmacology analysis
Kaijun Wang, Jie Yin, Jiayi Chen, et al.
Phytomedicine (2024) Vol. 128, pp. 155258-155258
Closed Access | Times Cited: 25
The Role of Natural Products and Their Multitargeted Approach to Treat Solid Cancer
Naoshad Muhammad, Darksha Usmani, Mohammad Tarique, et al.
Cells (2022) Vol. 11, Iss. 14, pp. 2209-2209
Open Access | Times Cited: 60
Remodeling tumor microenvironment with natural products to overcome drug resistance
Wanlu Zhang, Shubo Li, Chunting Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 38
Combining Crocin and Sorafenib Improves Their Tumor-Inhibiting Effects in a Rat Model of Diethylnitrosamine-Induced Cirrhotic-Hepatocellular Carcinoma
Basma Awad, Alaaeldin Ahmed Hamza, Amna Al-Maktoum, et al.
Cancers (2023) Vol. 15, Iss. 16, pp. 4063-4063
Open Access | Times Cited: 34
Modulation of the oxidative damage, inflammation, and apoptosis-related genes by dicinnamoyl-L-tartaric acid in liver cancer
Alaa Elmetwalli, Shimaa Mustafa Hashish, Mervat G. Hassan, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 11, pp. 3087-3099
Open Access | Times Cited: 20
Small-molecule-based targeted therapy in liver cancer
Ming Yue, Yanqiu Gong, Xuewen Fu, et al.
Molecular Therapy (2024) Vol. 32, Iss. 10, pp. 3260-3287
Closed Access | Times Cited: 9
The pharmacological properties of Gypsophila eriocalyx: The endemic medicinal plant of northern central Turkey
Merve İNANIR, Esra Uçar, Burak Tüzün, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 130943-130943
Closed Access | Times Cited: 8
Combination strategies for first-line treatment of patients with unresectable hepatocellular carcinoma: prospect of natural products
Lele Zhang, Jin‐Jian Lu
Chinese Journal of Natural Medicines (2024) Vol. 22, Iss. 1, pp. 1-3
Closed Access | Times Cited: 7
Pathogenic Th17 cell-mediated liver fibrosis contributes to resistance to PD-L1 antibody immunotherapy in hepatocellular carcinoma
Meiying Song, Luoyang Wang, Suli Jiang, et al.
International Immunopharmacology (2024) Vol. 129, pp. 111601-111601
Closed Access | Times Cited: 6
Preparation and Evaluation of Chitosan Coated PLGA Nanoparticles Encapsulating Ivosidenib with Enhanced Cytotoxicity Against Human Liver Cancer Cells
Bader B. Alsulays, Alhussain Aodah, Mohammad Ahmed, et al.
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 3461-3473
Open Access | Times Cited: 6
Hepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Lu-Qi Cao, Yuhao Xie, Joshua S. Fleishman, et al.
Cancer Letters (2024) Vol. 597, pp. 217061-217061
Closed Access | Times Cited: 6
MK-8776 and Olaparib Combination Acts Synergistically in Hepatocellular Carcinoma Cells, Demonstrating Lack of Adverse Effects on Liver Tissues in Ovarian Cancer PDX Model
Wiktoria Bębenek, Arkadiusz Gajek, Agnieszka Marczak, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 834-834
Open Access
Research progress on anti-aging effects and mechanisms of the new ginsenoside Compound K
Zhiqin Fang, Jingyin Zhang, Jianwen Huang, et al.
Deleted Journal (2025), pp. 100072-100072
Open Access
Recent Progress in Understanding the Action of Natural Compounds at Novel Therapeutic Drug Targets for the Treatment of Liver Cancer
Yannan Zheng, Wenhui Zhang, Lin Xu, et al.
Frontiers in Oncology (2022) Vol. 11
Open Access | Times Cited: 26
Anticancer Potential of Natural Chalcones: In Vitro and In Vivo Evidence
Radka Michalková, Ladislav Mirossay, Martin Kello, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 12, pp. 10354-10354
Open Access | Times Cited: 18
Immunotherapies for advanced hepatocellular carcinoma
Li‐Yang Sun, Kang-Jun Zhang, Ya-Ming Xie, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 15
A comprehensive review of phytoconstituents in liver cancer prevention and treatment: targeting insights into molecular signaling pathways
Md. Rezaul Islam, Abdur Rauf, Shopnil Alash, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 5
New thiazolidine-2,4-diones as potential anticancer agents and apoptotic inducers targeting VEGFR-2 kinase: Design, synthesis, in silico and in vitro studies
Hazem Elkady, Hazem A. Mahdy, Mohammed S. Taghour, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2024) Vol. 1868, Iss. 6, pp. 130599-130599
Closed Access | Times Cited: 4
Effect of anti-skin disorders of ginsenosides- A Systematic Review
Lele Cong, Jinli Ma, Yundong Zhang, et al.
Journal of Ginseng Research (2023) Vol. 47, Iss. 5, pp. 605-614
Open Access | Times Cited: 13
The cellular uptake of Cordyceps sinensis exopolysaccharide‑selenium nanoparticles and their induced apoptosis of HepG2 cells via mitochondria- and death receptor-mediated pathways
Xiao Zhang, Yidong Xiao, Qilin Huang
International Journal of Biological Macromolecules (2023) Vol. 247, pp. 125747-125747
Closed Access | Times Cited: 12
Cepharanthine, a regulator of keap1-Nrf2, inhibits gastric cancer growth through oxidative stress and energy metabolism pathway
Yangyang Lu, Chunyang Zhu, Yixin Ding, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Icaritin Derivative IC2 Induces Cytoprotective Autophagy of Breast Cancer Cells via SCD1 Inhibition
Yixuan Wang, Yi-Yuan Jin, Jie Wang, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1109-1109
Open Access | Times Cited: 11
A robust and validated LC–MS/MS method for the quantification of ramucirumab in rat and human serum using direct enzymatic digestion without immunoassay
Wen-si Huang, Weiqiang Li, Yu Xiong, et al.
Journal of Chromatography B (2024) Vol. 1234, pp. 123991-123991
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top